Replies to post #164782 on Biotech Values

[orphys13]

I recall in the front line trial of nilotinb vs imatinib the patients dosing nilotinib started at 400 mg and then dosed down to 300 mg.

[JJM760]

Please tell me ole wise soothsayer, why with all these great, potentially monster catalysts, does Aria stock SUCK so much these days?